Physician profile
Erik C Johnson
NPI 1538134341
$9,075.69
in general payments reported to CMS, 2019-2025
15 companies · $7,656 in 2025
The $7,656 reported for 2025 was more than what 86% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $248 · 2020: $106 · 2021: $133 · 2022: $377 · 2023: $402 · 2024: $154 · 2025: $7,656.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,850 · Travel and Lodging: $1,393 · Food and Beverage: $969.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,850.00 |
| Travel and Lodging | $1,393.09 |
| Food and Beverage | $968.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $7,450.04 | 2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Bone Anchors With Arthroscopic Delivery System, Pico |
| Depuy Synthes Sales INC. | $444.57 | 2019-2025 | Na, Versalok Orthocord, Dynatape |
| Boehringer Ingelheim Pharmaceuticals, INC. | $425.13 | 2019-2025 | Jardiance, Tradjenta, Glyxambi |
| Fidia Pharma USA INC. | $215.83 | 2019-2025 | Triluron, Hymovis |
| Peerless Surgical INC. | $129.08 | 2022-2024 | |
| Sanofi-Aventis U.S. LLC | $98.84 | 2022-2023 | |
| Saluda Medical Americas, INC. | $75.91 | 2023 | Evoke Scs |
| Stryker Corporation | $62.36 | 2022-2025 | Tornier Perform Reversed Augmented Glenoid, Aequalis Perform |
| Pacira Therapeutics, INC. | $49.44 | 2019-2020 | |
| Myoscience INC. | $31.63 | 2019 | |
| Heron Therapeutics, INC. | $24.41 | 2024 | Zynrelef |
| Vericel Corporation | $23.79 | 2022 | |
| Ermi LLC | $19.45 | 2021 | |
| Medacta USA, INC. | $16.58 | 2023 | Reverse Shoulder |
| Ossur Americas, INC. | $8.63 | 2024 | Miami J |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erik Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.